iRadimed registers for a $12 million initial public offering in support of its non-magnetic IV infusion pump systems. iRadimed plans $11.5M IPO for MRI-safe IVs
Florida-based device maker iRadimed is looking to raise up to $12 million through an initial public offering, hoping to use the funds to expand its sales & marketing efforts and boost research & development for its MRI-friendly infusion pumps.
Help employers find you! Check out all the jobs and post your resume.
